# Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma

> **NCT01404013** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 99 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ICS/LABA
- **DRUG:** Montelukast
- **DRUG:** ICS/LABA and Montelukast

## Key facts

- **NCT ID:** NCT01404013
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2014-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404013, "Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01404013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*